Mapa mental
Cisplatin

Contenido del mapa
Cisplatin
Platinol-AQ & Platinol (Brand Names)
Cancers Treated
- Metastatic Testicular Tumors
- Metastatic Ovarian Tumors
- Advanced Bladder Cancer
- Metastatic Ovarian Tumors
- First-Line Treatment of Ovarian Cancer
- Unlabeled Uses
- Non-Small-Cell Lung Cancer
- Brain Cancer
- Adrenal Cortex Cancer
- Breast Cancer
- Cervix Cancer
- Uterine Cancer
- Endometrium Cancer
- Head and Neck Cancer
- Esophogeal Cancer
- Lung Cancer
- Liver Cancer
- Osteogenic Sarcomas
- Numerous Other Malignancies
- Osteogenic Sarcomas
- Liver Cancer
- Lung Cancer
- Esophogeal Cancer
- Head and Neck Cancer
- Endometrium Cancer
- Uterine Cancer
- Cervix Cancer
- Breast Cancer
- Adrenal Cortex Cancer
- Brain Cancer
- Non-Small-Cell Lung Cancer
- Unlabeled Uses
- Metastatic Testicular Tumors
Drug Classification
- Platinum Based Antineoplastic
Drug Reconstitution & Dilution
- Comes in a liquid form so no reconstitution is required
- Combined with Mannitol in either NS or D5 1/2 NS 1/2. D5W alone cannot be used.
- Comes in a liquid form so no reconstitution is required
Physiological Concepts
- Evidence of Tumors
- Symptoms will vary depending on the type of cancer
- Evidence of Tumors
Non-Drug Treatments or Lifestyle Modifications
- Use of essential oils
- Super Foods
- Nutrients, Foods & Products that help to build up the immune system
- Get plenty of rest
- Exercise
- Get to and maintain a healthy weight
- Exercise
- Get plenty of rest
- Nutrients, Foods & Products that help to build up the immune system
- Super Foods
- Use of essential oils
Routes of Administrtion
- Can be used in all populations. Pediatric patients need close monitoring and testing. IV USE ONLY!!
Usual Dose & Rate of Administration
- Dose & Rate will Vary based on patient. Dosed using BSA. Not to be run as a rapid infusion. Typically run over 2 hours
Contraindications & Warnings
- Hypersensitivity to cisplatin or other platinum-containing compounds.
- Myelosuppressed Patients
- Patients with pre-existing impaired renal function
- Patients with a hearing deficit
- Pregnancy Risk Category D
- Patients with a hearing deficit
- Patients with pre-existing impaired renal function
- Myelosuppressed Patients
- Hypersensitivity to cisplatin or other platinum-containing compounds.
Antidote for Patient Reaction
- There is no specific antidote available
- Discontinue Use
- Administration of whole blood products
- Discontinue Use
- There is no specific antidote available
Drug Drug Interactions
- Aminoglycosides (i.e. Gentamicin)
- Loop Diuretics (i.e furosemide)
- Anticonvulsant Agents
- Ohter Antineoplastic agents
- Live Virus Vaccines
- Drug Food Interactions
- None
- Drug Food Interactions
- Live Virus Vaccines
- Ohter Antineoplastic agents
- Anticonvulsant Agents
- Loop Diuretics (i.e furosemide)
- Aminoglycosides (i.e. Gentamicin)
Ongoing Monitoring
- Side effects should be monitored closely as they can be frequent and become more severe with every dose after the fist.
- Hearing tests are ordered for high dose therapies
- Blood Tests such as a CBC will be done to monitor electrolytes and organ functions
- Hearing tests are ordered for high dose therapies
- Side effects should be monitored closely as they can be frequent and become more severe with every dose after the fist.
Interesting Fact: First platinum-containing anti-cancer drug
Imágenes y archivos del mapa
Información
- Descripción
- Cisplatin Mindmap for Chemotherapy Unit in Sterile Compounding Class
- Creado por
- Jodie Evans
- Visitas
- 22
- Etiquetas
- Valoración